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Introduction

2
The use of urine as a readily-available biofluid for the development of novel diagnostics is a clear 3 area of significant potential for clinical studies. Obtaining urine samples is trivial, non-invasive and 4 highly acceptable to patients. Urine samples are widely used in diagnostic assays for renal function, 5 drug metabolism and toxicology screens to detect recreational drug use and misuse of drugs in 6 sports and 1 2 . In comparison to whole blood, urine is stable and has both lower complexity and a 7 reduced dynamic range 3 . If we can reliably observe markers of disease in urine samples, 8 development of urine tests therefore forms a highly-desirable development area for clinical 9
diagnostics. 10
Urine is formed via filtration of blood plasma in the kidney, and is principally comprised of water, 11 sugars, amino acids and inorganic salts 4 . In general, intact proteins are not passed into urine due to 12 their high molecular weights, and selective reabsorption of major serum proteins (albumin, 13 immunoglobulins) via specific receptor molecules removes the bulk of this protein from the urine. 14 The protein content of urine in normal healthy subjects is therefore typically low (30-150 mg/day) 5 . 15
In pregnancy, kidney size and functional capacity are altered in response to rising progesterone 16 levels, to facilitate an increased blood volume, encompassing the additional excretory requirements 17 of the fetoplacental unit. This growth in renal capacity enables increased glomerular filtration 18 requirements to be managed 6 . Raising the glomerular filtration rate influences the protein excretion 19 via urine, resulting in a significant increase in urinary protein excretion in normal pregnancy 5 , and 20 higher concentrations of both intact proteins and proteolytic products of proteins in the urine. 21
Processed proteolytic products of proteins (or endogenous peptides) within urine are of interest as 22 potential diagnostics for a number of reasons. Firstly, extremely low levels of peptides are robustly 23 detectable in biofluids such as urine, with as low as attomole levels of detection being routine on 24 modern tandem quadrupole instrumentation for targeted analysis at medium-to high-throughput; 25 moreover, high levels of accuracy and low false positive rates are readily achieved 7 . Analysis of urine 26 samples represents a rich source of polypeptide molecules as biomarkers for disease conditions, 27
with approximately a ten-fold molar excess of peptides over proteins being excreted each day 8 . 28
Proteolysis is altered in a number of disease conditions 9 10 , therefore observing the altered actions 29 of proteases upon the peptidome is ultimately likely to yield information as to the pathogenesis of 30 the condition as well as generating novel diagnostic strategies. 31 M a n u s c r i p t 4 A significant body of work exists in the field of urinary proteomics, with between 1500 and 2300 1 proteins having been identified as components of urine 11 12 , following combined approaches 2 incorporating GeLC-MS and shotgun proteomics of proteins following centrifugal concentration. For 3 example, using a capillary electrophoresis-time-of-flight mass spectrometry approach, a panel of 4 marker peptides were selected from urine polypeptides (nominal molecular weight <20kDa) which 5 delineated prostate cancer patients from normal controls 13 ; a limited number of these markers 6 were amenable to routine identification via collision induced dissociation (CID). 7
In recent years, electron-mediated dissociation techniques, initially electron capture dissociation 8 (ECD) and latterly electron transfer dissociation (ETD) have been applied to peptides 14 . In 9 comparison with CID, the cleavage observed has been shown to provide more complete sequence 10 coverage, with fewer second-and third generation product ions being observed than in CID-11 generated product ion spectra; this is particularly valuable for longer polypeptides Application of electron transfer dissociation to the analysis and identification of native urinary 27 polypeptides has, to our knowledge, never previously been performed. We therefore apply this 28 advanced technique for peptide dissociation to this class of analyte to demonstrate the feasibility of 29 the approach for normal human urine samples, taken from pregnant subjects. We compare the data 30 generated from the two typical fragmentation techniques used within conventional switching 31 experiments (CID and ETD). Within this dataset we find a large number of peptides with 32 physicochemical characteristics precluding ready identification by collisional dissociation, many ofM a n u s c r i p t 5 which are amenable to identification using ETD. 1 M a n u s c r i p t 6 1
Material and methods
2
Samples
3
Urine samples were obtained from low risk nulliparous women with singleton pregnancies recruited 4 to the Screening fOr Pregnancy Endpoints (SCOPE) study were studied 26 . The exclusion criteria and 5 inclusion criteria have been described in detail elsewhere 27 . Each participant was interviewed by a 6 research midwife at 14-16 weeks of gestation and detailed clinical information was collected, as 7 previously described 28 ; Mid-steam urine specimens were collected at this antenatal attendance, 8 processed within 4 hours, and stored at -80°C. Women were tracked prospectively and information 9 about pregnancy outcomes was obtained; any subject who subsequently developed a pregnancy 10 complication was excluded from the study. 11
Preparation of urine sample
12
Samples were shipped on dry ice and subsequently prepared using a modified version of a 13 previously-published protocol 3 . Urine samples were thawed and spun to pellet urinary tract cellular 14 debris (3,000 rpm, 4°C, 20 min). Peptides were separated from proteins (arbitrary NMWCO of 15 10kDa) using centrifugal concentrators (Vivaspin 20, Sartorius AG), with the spin through peptide 16 fraction being subjected to solid phase extraction (SPE) to concentrate and clean up the peptides. 17 SPE was performed using HLB cartridges (Aldrich), which were used according to manufacturers' 18 instructions, eluting bound materials using 60% acetonitrile, 0.1% trifluoracetic acid. SPE-eluted 19 components were subjected to strong cation exchange treatment to segregate bile components 20 from peptides. This was performed as per the protocol of Cutillas 3 , using bulk SCX media 21 (polysulphoethyl A, PolyLC, Columbia MD). Peptides were eluted in 500 mM ammonium acetate in 22 20 % ACN, volatile buffer components were then removed by vacuum centrifugation prior to 23 peptides being subjected to LC-MS/MS analysis. 24 The number of polypeptides (cleaved from originating precursor proteins) which were confidently 29 identified by ETD substantially outnumbered those identified by CID in our dataset (Fig 1) , both inA c c e p t e d M a n u s c r i p t 8 terms of unique spectra and unique peptides observed. Manual examination of a subset of survey 1 and product ion spectra indicated several reasons for this. One proposed explanation for the 2 disparity in identification frequency from the two ion activation methods is attributed to intrinsic 3 properties of the peptides. An abundance of large precursor ions bearing high charge states (z≥4) 4 was observed in typical survey spectra (exemplified in Fig 2a) . Previous studies have proposed that 5 larger highly-charged precursors show poor fragmentation properties by CID due to vibrational 6 energy dissipation 33 ; ETD effectively fragments such species 9, 34 . Qualitative assessment of example 7 CID product ion spectra (Fig 2b) in cases where successful identification was made by ETD (Fig 2c),  8 but not using collisional dissociation, indicated a strong difference in the quality of the product ion 9 spectra. In the example case, a number of sequence-related product ions could be manually 10 assigned to the product ion spectrum using sequence information derived from the ETD-based 11 identification data (Fig 2b) . The lack of CID-based identification is likely to derive from both the mass 12 spectrometric methodology utilised in our analyses and the resultant database searching 13 parameters. Spectra were acquired in low resolution mode using the ion trap, providing product ion 14 spectra with low mass accuracy (0.6Da product ion tolerance being used in our database search). 15
LC-MS/MS analysis of urinary peptides
This reduces the likelihood of making above-threshold identifications. Increased mass accuracy, 16 achieved via using the high-resolution mass spectrometer, would remove this problem; poor 17 efficiency of ion transfer however meant that this was not performed in this particular analysis. A 18 further contribution to the poor identification of polypeptides in this dataset using collisional 19 dissociation is that, in contrast to tryptic peptides, a number of polypeptides lack C-terminal basic 20 residues (Fig 3, Supplementary Data ). The precise location of basic residues within peptide sequence 21 is known to strongly influence peptide fragmentation by CID, with a potential source of difficulties in 22 non-tryptic peptide identification resulting from the formation of non-canonical (scrambled) product 23 ions 35 . 24
The majority of peptides observed in our dataset have molecular weights of less than 5kDa (Fig 2a,  25 Supplementary Data: Scaffold Reports). Whilst the natural distribution of polypeptidic species in the 26 urine samples is reasonably likely to be biased towards species of lower molecular weight, the use of 27 centrifugal filters in sample preparation and the tuning parameters of the mass spectrometer will 28 have made additional contributions to this observation. Tuning parameters favouring larger 29 polypeptides, and the use of larger poresize filters for sample preparation, could see an increase in 30 the net molecular weight of polypeptide species observed.M a n u s c r i p t originating from abundant proteins were identified within urine samples, including uromodulin, a 6 64kDa glycoprotein expressed in the kidney and secreted into urine, whose functions are believed to 7 be in regulating colloid pressure of the urine and regulating inflammation processes in the urinary 8 tract. High-confidence product ion data were generated for polypeptide species pertaining to the C-9 terminal region of the mature protein sequence, which is removed from the mature protein by 10 cleavage during its secretion, representing products which derive from the non-secreted domain 36 . 11
A number of closely-related 'ragged' peptides with overlapping sequences, differing in precise site of 12 cleavage were observed both for this parent protein and for other precursors identified. This reflects 13 heterogeneity in the cleavage mechanisms involved during proteolytic processing of these species 14 (see Supplementary Table 1) . 15
Protein-derived polypeptides with sequences derived from osteopontin were also observed in these 16 samples (see Supplementary Table 2 ). Osteopontin is a protein which has been shown by some 17 groups to have a positive correlation with endothelial damage in the pregnancy complication pre-18 eclampsia; altered levels of osteopontin have been observed in pregnancies complicated by pre-19 eclampsia, as compared to uncomplicated pregnancies, in both trophoblast 37 and plasma
38
. The 20 method as developed is therefore capable of assigning polypeptide sequences to biologically-21 relevant species. 22
Polypeptides analysed within this study were not subjected to targeted in vitro enzymolysis, as a 23 goal of this experiment was to observe any emergent patterns in proteolytic action upon identified 24 peptide species. (Fig 3) No clear patterns were observed in this analysis, bar an abundance of 25 uncharged glycine residues throughout the peptides, and a small over-representation of basic amino 26 acid residues, particularly lysines, near peptide termini. Detailed analysis of this phenomenon is 27 beyond the scope of the present manuscript, and overinterpretation of these trends should be 28 avoided, as these observations could result from a combination of the cleavage properties of 29 endoproteinases active at some stage in the generation or preparation of these biological sample, or 30 from inherent properties of peptides whose fragmentation properties are favoured by ETD and 31 which were therefore identified, and are thus predominant in this dataset. The relative 32 contributions of these factors remain unknown. Low resolution (linear ion trap) data were generated for all product ion spectra; this was largely to 10 retain sensitivity, speed and parallel nature of analyses, thus maximising the duty cycle of the 11 analyses performed and number of peptides confidently identified. Transmission efficiency of ions 12 to the orbitrap using the older-generation hybrid LTQ Orbitrap XL instrument was sufficiently low to 13 have a significant adverse impact upon intensity of product ion spectra, and concomitant 14 detrimental effect upon sequence assignment in preliminary experiments (data not shown). Use of 15 the ion trap increased sensitivity for product ion analysis, but the low resolution of the product ion 16 analyses has implications both for false discovery rate of peptide identification data, and reliability of 17 observed products' charge states . A further advantage of a high resolution survey/high-resolution product ion spectrum approach 23 is the ability to include post-translational modifications and polymorphisms as variable search 24 modifications. These important biological entities could not be not included in our study due to the 25 massive search space of "no-enzyme" searches, but form an part of normal human variation, with 26 polymorphisms being largely unrepresented in standard database searching methods 23 . Future 27 studies incorporating high-resolution product ion data could begin to encompass this information. 28
Conclusions
29
This study applies ETD to the analysis of urinary polypeptides in the urine of pregnant women with 30 uncomplicated outcomes. Survey spectra were typically extremely rich in multiply-charged 31 M a n u s c r i p t precursor ions, meaning that relatively few peptides/proteins were identified using conventional 1
MS/MS with CID. 2
The use of peptidomics methodologies has the potential to enhance the accuracy of prediction or 3 diagnosis of pregnancy complications. For example, almost 1 in 20 first pregnancies are complicated 4 by pre-eclampsia, a disease characterized by the co-occurrence of hypertension and proteinuria. 5
The condition is associated with serious maternal and perinatal morbidity and mortality, accounting 6 for 70,000 maternal and 500,000 infant deaths annually 39 40 . Identification of risk of pre-eclampsia 7 is the first step to effective intervention and prevention, however, the overwhelming majority of first 8 time mothers have no identifiable clinical risk factors in early pregnancy 28 . Although urinary 9 proteomic profiling of pregnancies complicated by pre-eclampsia has been attempted 41 42 43 , the 10 methodologies used have not been able to discriminate between normal and pre-eclampsia 11 pregnancies at gestations early enough to enable preventative strategies. It remains to be 12 determined whether our approach, employing enhanced polypeptide identification of native urinary 13 proteolytic fragments, achieved with the assistance of ETD, will eventually lead to a clinically useful 14 predictive test. Mascot matches to typical product ion spectra from CID and ETD-based product ion analysis. A) 7
Identified 'proteins' (multiple urinary polypeptides matching to a single SwissProt entry) from 8 dataset at 95% protein threshold (1.4% reported FDR). B) Identified peptides from dataset at 95% 9 peptide threshold (0.26% decoy FDR). 10 ). Predicted product ion species from this sequence are annotated on both B) and C), 18 with manual assignment of unambiguous product ions within 0.6Da mass tolerance to CID spectrum 19 B) being derived from reported sequence identification data obtained from ETD. 20 
